| Application no. and date | 17702164.9 (espacenet) (Federated) (European Patent Register), 20170123 | | Patent/reg. no. and date | DK/EP 3411004, 20210310 | | Publication date | 20181212 | | Priority no. and date | US 201662291589 P, 20160205 | | EP pub. no. and date |
EP 3411004 20181212 | | Effective date | | | Applicant/owner | InnoPharma, Inc., 235 East 42nd Street
New York, NY 10017, US | | Applicant ref. no. | V52465DK00 | | Inventor | KUNADHARAJU, Sasank Chaitanya, 32 Stony Road
Edison, New Jersey 08817, US,
HINGORANI, Tushar, 84 Royal Drive
Apartment No. 321
Piscataway, New Jersey 08854, US,
PEJAVER, Satish, 563 Glen Ridge Drive South
Bridgewater, New Jersey 08807, US,
MALKAN, Tushar, 32 DARBY CT
INDIAN CREEK IL 60061-3271, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61J 1/10 (2006.01) , A61K 31/167 (2006.01) , A61K 9/08 (2006.01) , A61L 2/07 (2006.01) | | Title | Fremgangsmåde til fremstilling af en stabil, brugsklar infusionspose til en oxidationsfølsom formulering | | Int. application no. | IB2017050341 | | Int. publication no. | WO2017134540 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
